Douglas R. Vogus
Douglas R. Vogus
Harvard (Postdoc, SEAS), UCSB (PhD, Chem Eng), Bucknell (BS, Chem Eng)
Verifierad e-postadress på g.harvard.edu
Titel
Citeras av
Citeras av
År
Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting
AC Anselmo, M Zhang, S Kumar, DR Vogus, S Menegatti, ME Helgeson, ...
ACS nano 9 (3), 3169-3177, 2015
3082015
Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries
AC Anselmo, CL Modery-Pawlowski, S Menegatti, S Kumar, DR Vogus, ...
ACS nano 8 (11), 11243-11253, 2014
2152014
Synergistic antitumor activity of camptothecin–doxorubicin combinations and their conjugates with hyaluronic acid
KM Camacho, S Kumar, S Menegatti, DR Vogus, AC Anselmo, ...
Journal of Controlled Release 210, 198-207, 2015
692015
Using bulk convection in a microtensiometer to approach kinetic-limited surfactant dynamics at fluid–fluid interfaces
NJ Alvarez, DR Vogus, LM Walker, SL Anna
Journal of colloid and interface science 372 (1), 183-191, 2012
592012
DAFODIL: a novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy
KM Camacho, S Menegatti, DR Vogus, A Pusuluri, Z Fuchs, M Jarvis, ...
Journal of Controlled Release 229, 154-162, 2016
442016
A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
DR Vogus, MA Evans, A Pusuluri, A Barajas, M Zhang, V Krishnan, ...
Journal of Controlled Release 267, 191-202, 2017
432017
A review on engineering polymer drug conjugates to improve combination chemotherapy
DR Vogus, V Krishnan, S Mitragotri
Current opinion in colloid & interface science 31, 75-85, 2017
412017
Treating tumors at low drug doses using an aptamer–peptide synergistic drug conjugate
A Pusuluri, V Krishnan, V Lensch, A Sarode, E Bunyan, DR Vogus, ...
Angewandte Chemie International Edition 58 (5), 1437-1441, 2019
242019
Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro‐in vivo correlation
DR Vogus, A Pusuluri, R Chen, S Mitragotri
Bioengineering & translational medicine 3 (1), 49-57, 2018
192018
Measuring concentration fields in microfluidic channels in situ with a Fabry–Perot interferometer
DR Vogus, V Mansard, MV Rapp, TM Squires
Lab on a Chip 15 (7), 1689-1696, 2015
132015
Design principles of drug combinations for chemotherapy
D Wu, A Pusuluri, D Vogus, V Krishnan, CW Shields IV, J Kim, A Razmi, ...
Journal of Controlled Release 323, 36-46, 2020
102020
Programmable Delivery of Synergistic Cancer Drug Combinations Using Bicompartmental Nanoparticles
JV Gregory, DR Vogus, A Barajas, MA Cadena, S Mitragotri, J Lahann
Advanced Healthcare Materials 9 (21), 2000564, 2020
12020
Polymer-drug conjugates for combination anticancer therapy
KM Camacho, S Menegatti, S Kumar, D Vogus, S Mitragotri
US Patent 10,653,789, 2020
12020
Design strategies for engineering soluto-inertial suspension interactions
A Banerjee, DR Vogus, TM Squires
Physical Review E 100 (5), 052603, 2019
12019
Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
D Wu, D Vogus, V Krishnan, M Broto, A Pusuluri, Z Zhao, N Kapate, ...
Pharmaceutics 13 (1), 107, 2021
2021
Polymer-drug conjugates for combination anticancer therapy
KM Camacho, S Menegatti, S Kumar, D Vogus, S Mitragotri
US Patent App. 16/846,707, 2020
2020
Polymeric vehicles for the optimal delivery of synergistic chemotherapeutics
D Vogus
UC Santa Barbara, 2017
2017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–17